Richard Knox
Since he joined NPR in 2000, Knox has covered a broad range of issues and events in public health, medicine, and science. His reports can be heard on NPR's Morning Edition, All Things Considered, Weekend Edition, Talk of the Nation, and newscasts.
Among other things, Knox's NPR reports have examined the impact of HIV/AIDS in Africa, North America, and the Caribbean; anthrax terrorism; smallpox and other bioterrorism preparedness issues; the rising cost of medical care; early detection of lung cancer; community caregiving; music and the brain; and the SARS epidemic.
Before joining NPR, Knox covered medicine and health for The Boston Globe. His award-winning 1995 articles on medical errors are considered landmarks in the national movement to prevent medical mistakes. Knox is a graduate of the University of Illinois and Columbia University. He has held yearlong fellowships at Stanford and Harvard Universities, and is the author of a 1993 book on Germany's health care system.
He and his wife Jean, an editor, live in Boston. They have two daughters.
-
India's Supreme Court says drug maker Novartis can't hold onto its patent for the pricey cancer drug Gleevec simply by tweaking its chemical formula. That means generic drug makers can keep making a form of the drug at a tenth of Novartis's price. Consumer advocates call it a major advance for access to generic drugs. The drug industry says it will chill companies' willingness to produce innovative products.
-
Women who took aspirin at least a couple of times a week for five years or more cut their risk of melanoma by 30 percent. The new study adds to the mounting pile of research suggesting that cheap, common aspirin lowers the risk of many cancers, including colon, breast, esophagus, stomach, prostate, bladder and ovarian cancer. -
Two out of three Americans living with hepatitis C infection are baby boomers, and many will never know the source of their infection. Drugs to treat the disease have many side effects, but dozens of new ones are in the pipeline. -
On the third anniversary of Haiti's devastating earthquake, the country is laying plans to rid itself of the cholera epidemic that followed in its wake. Most scientists now think Nepalese soldiers unwittingly spread the pathogen in Haiti when they joined a United Nations peacekeeping force. -
The 2012 mammography debate was a continuation of a controversy touched off three years ago when a government task force said women under 50 don't need regular mammograms. And one recent analysis found that regular screenings haven't reduced the rate of advanced breast cancers. -
The mold is so rare as a cause of human illness that nobody knows its incubation period. That makes it hard to predict when the outbreak will be over. -
A Meningitis outbreak occurred after a steroid drug commonly injected into people's spines to relieve back pain was apparently contaminated by an ordinary fungus. The problem shines a light on little-known and lightly regulated companies called compounding pharmacies.
-
A steroid drug administered to relieve back pain has been contaminated by the spores of a common leaf mold. Five deaths have been reported so far. -
The Swedish team transplanted uteruses from two women in their 50s to their daughters, and an Indiana group is recruiting women willing to undergo womb transplants in this country. It's the latest frontier in a field launched in 1954 with a successful kidney transplant. But one expert cautions against premature enthusiasm. -
A recent study found 1 in 10 American men and 1 in 14 women has had a kidney stone. Being obese or diabetic seems to raise the risk of getting them. Now lasers are becoming the treatment-of-choice for kidney stones in academic medical centers.
